Yao Kang Biological: After two rounds of repurchase, differential dividends will be implemented, with a planned cash dividend of 12.2691 million yuan.

Yaoke Biotechnology announced that the company's two-phase repurchase plan has repurchased a total of 3.07 million shares. On June 6, 2025 and October 27, 158,000 and 460,000 shares of employee stock ownership plan were respectively transferred non-traditionally. As of the date of the verification opinion, the repurchase special securities account held 1.03 million shares. The company's 2025 semi-annual equity distribution implemented differentiated dividends, intending to distribute 0.3 yuan to all shareholders for every 10 shares, with a total of 122.691 million yuan to be distributed based on 408.97 million shares. The sponsor believes that the current differentiated dividends are in compliance with regulations and do not harm the interests of the company and shareholders.